{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:31:01Z","timestamp":1773826261645,"version":"3.50.1"},"reference-count":20,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Western Norway Regional Health Authority, Norway"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>CXCL5 is a platelet-derived chemokine which promotes inflammatory responses in neutrophils and monocytes through CXCR2. Previous studies on CXCL5 in atherogenesis are to some degree conflicting, with scarce outcome data following acute coronary syndrome. This study aimed to assess the utility and risk profile of CXCL5 as a prognostic marker of all-cause mortality at 5-year follow-up in patients hospitalized for chest pain of suspected coronary origin. We measured CXCL5 levels in platelet-poor plasma in 826 consecutive patients included in the \u201cRisk Markers in the Acute Coronary Syndrome\u201d (RACS) study (ClinicalTrials.gov Identifier: NCT00521976). Stepwise Cox regression models, applying quintiles, were fitted for the biomarker with all-cause mortality within 5 years as the dependent variable. At 5-year follow-up, 250 (30.3%) of the population had died; 34.5% in Quintile (Qt)-1, 32.1% in Qt-2, 23.5% in Qt-3, 29.1% in Qt-4, and 32.1% in Qt-5. Using Qt-3 as a reference, both the univariate and multivariable analysis showed a U-shaped association between CXCL5 and all-cause mortality. Univariate analysis: Qt-1 vs. Qt-3: HR 1.59 (95% CI 1.06\u20132.39), p = 0.026, and Qt-5 vs. Qt-3: HR 1.44 (0.95\u20132.18), p = 0.082, respectively. Multivariable analysis: Qt-1 vs. Qt-3: HR 1.65 (1.09\u20132.48), p = 0.017, and Qt-5 vs. Qt-3: HR 1.52 (1.00\u20132.30), p = 0.049, respectively. The U-shaped relationship was statistically strengthened, employing a composite endpoint consisting of all-cause mortality, MI or stroke. Our findings suggest that both too-low and too-high levels of CXCL5 may be harmful in patients admitted to hospital with chest pain of suspected coronary origin.<\/jats:p>","DOI":"10.3390\/ijms27062744","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:35:08Z","timestamp":1773819308000},"page":"2744","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C-X-C Motif Chemokine Ligand 5 (CXCL5) Exhibits a U-Shaped Risk Profile for Mortality in Patients with Suspected Coronary Chest Pain"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6142-6863","authenticated-orcid":false,"given":"Dennis Winston T.","family":"Nilsen","sequence":"first","affiliation":[{"name":"Department of Clinical Science, University of Bergen, 5021 Bergen, Norway"},{"name":"Department of Cardiology, Stavanger University Hospital, 4068 Stavanger, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrycja Anna","family":"Naesgaard","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Stavanger University Hospital, 4068 Stavanger, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volker","family":"Poenitz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Stavanger University Hospital, 4068 Stavanger, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trygve","family":"Brugger-Andersen","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Stavanger University Hospital, 4068 Stavanger, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi","family":"Grundt","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Stavanger University Hospital, 4068 Stavanger, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7207-2407","authenticated-orcid":false,"given":"Annika Elisabet","family":"Michelsen","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway"},{"name":"Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P\u00e5l","family":"Aukrust","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway"},{"name":"Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway"},{"name":"Section of Clinical Immunology and Infectious Diseases, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1135-5221","authenticated-orcid":false,"given":"Harry","family":"Staines","sequence":"additional","affiliation":[{"name":"Sigma Statistical Services, Balmullo KY16 0BD, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5005-0784","authenticated-orcid":false,"given":"Thor","family":"Ueland","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318 Oslo, Norway"},{"name":"Research Institute of Internal Medicine, Oslo University Hospital, Rikshospitalet, 0372 Oslo, Norway"},{"name":"Thrombosis Research Center (TREC), Division of Internal Medicine, University Hospital of North Norway, 9037 Troms\u00f8, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Murphy, P.M. (2019). Chemokines and Chemokine Receptors. Clinical Immunology, Elsevier. [5th ed.]. Principles and Practice.","DOI":"10.1016\/B978-0-7020-6896-6.00010-7"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: Pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/ATVBAHA.107.161240","article-title":"Chemokines and cardiovascular risk","volume":"28","author":"Aukrust","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/ATVBAHA.118.312037","article-title":"Chemokines as therapeutic targets in cardiovascular disease","volume":"39","author":"Noels","year":"2019","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0008-6363(99)00262-X","article-title":"CXC-chemokines, a new group of cytokines in congestive heart failure\u2014Possible role of platelets and monocytes","volume":"45","author":"Gullestad","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Guo, L., Li, N., Yang, Z., Li, H., Zheng, H., Yang, J., Chen, Y., Zhao, X., Mei, J., and Shi, H. (2021). Role of CXCL5 in regulating chemotaxis of innate and adaptive leukocytes in infected lungs upon pulmonary influenza infection. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.785457"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"20539","DOI":"10.1074\/jbc.M116.745265","article-title":"Molecular basis of CXCL5-glycosaminoglycan interactions","volume":"291","author":"Sepuru","year":"2016","journal-title":"J. Biol. Chem."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.molcel.2025.01.024","article-title":"Molecular basis of promiscuous chemokine binding and structural mimicry at the C-X-C chemokine receptor, CXCR2","volume":"85","author":"Saha","year":"2025","journal-title":"Mol. Cell"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1161\/01.RES.0000160077.17427.57","article-title":"Platelets and chemokines in atherosclerosis: Partners in crime","volume":"96","author":"Weber","year":"2005","journal-title":"Circ. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/01.RES.0000252802.25497.b7","article-title":"Platelets as immune cells: Bridging inflammation and cardiovascular disease","volume":"100","author":"Weber","year":"2007","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1538-7836.2003.00065.x","article-title":"CXC-chemokines in coronary artery disease: Possible pathogenic role of interactions between oxidized and peripheral blood mononuclear cells","volume":"1","author":"Holm","year":"2003","journal-title":"J. Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1365-2265.2011.04119.x","article-title":"Serum CXC ligand 5 is a new marker of subclinical atherosclerosis in type 2 diabetes","volume":"75","author":"Chen","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/MCA.0000000000000292","article-title":"CXCL5 is associated with the increased risk of coronary artery disease","volume":"26","author":"Wang","year":"2015","journal-title":"Coron. Artery Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI66580","article-title":"CXCL5 limits macrophage foam cell formation in atherosclerosis","volume":"123","author":"Rouselle","year":"2013","journal-title":"J. Clin. Investig."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1016\/j.ajpath.2017.08.006","article-title":"Clinical evidence supports a protective role for CXCL5 in coronary artery disease","volume":"187","author":"Ravi","year":"2017","journal-title":"Am. J. Pathol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1159\/000537919","article-title":"\u03b11-antichymotrypsin complex (SERPINA3) is an independent predictor of all-cause but not cardiovascular mortality in patients hospitalized for chest pain of suspected coronary origin","volume":"149","author":"Nilsen","year":"2024","journal-title":"Cardiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"194","DOI":"10.21037\/atm.2016.05.19","article-title":"An historical approach to the diagnostic biomarkers of acute coronary syndrome","volume":"4","author":"Danese","year":"2016","journal-title":"Ann. Transl. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zineh, I., Beitelshees, A.L., Welder, G.J., Hou, W., Chegini, N., Wu, J., Cresci, S., Province, M.A., and Spertus, J.A. (2008). Epithelial neutrophil-activating peptide (ENA-78), acute coronary syndrome prognosis, and modulatory effect of statins. PLoS ONE, 3.","DOI":"10.1371\/journal.pone.0003117"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1111\/febs.14466","article-title":"A guide to chemokines and their receptors","volume":"285","author":"Hughes","year":"2018","journal-title":"FEBS J."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2744\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T07:36:23Z","timestamp":1773819383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/6\/2744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":20,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27062744"],"URL":"https:\/\/doi.org\/10.3390\/ijms27062744","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}